These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 782971)

  • 1. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS
    Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.
    White WG; Freestone DS; Bowker CH; Barnes GM; Letley E; Ferris RD
    Dev Biol Stand; 1976; 33():202-6. PubMed ID: 782970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria in the evaluation of live intranasal influenza virus vaccines.
    Zygraich N
    Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of man and animals against influenza by oral and intranasal routes.
    Boudreault A; Boulay G; Marois P; Pavilanis V
    Dev Biol Stand; 1976; 33():171-7. PubMed ID: 782965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural challenge of subjects vaccinated with WRL 105 strain live influenza vaccine in a residential community.
    Morris CA; Freestone DS; Stealey VM
    Dev Biol Stand; 1976; 33():197-201. PubMed ID: 782969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live attenuated influenza virus vaccine trial in children.
    Hall CB; Douglas G; Fralonardo SA
    Pediatrics; 1975 Dec; 56(6):991-8. PubMed ID: 1196767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of live attenuated influenza vaccine ts-1(E) in man.
    Gwaltney JM
    Dev Biol Stand; 1976; 33():178-83. PubMed ID: 782966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
    Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of oral influenza vaccination with live attenuated viruses.
    DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G
    Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of live recombinant influenza vaccine.
    Stealey VM; McCahon D; Freestone DS
    Dev Biol Stand; 1976; 33():191-6. PubMed ID: 955267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated influenza virus vaccines in patients with chronic broncho-pulmonary diseases. Clinical and immunological evaluation.
    Prevost JM; Vereerstraeten-Schmerber J; Lamy F; De Koster JP
    Scand J Respir Dis; 1975 May; 56(1):58-69. PubMed ID: 1096297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience of nasal application of inactivated influenza vaccine.
    Fukumi H
    Dev Biol Stand; 1976; 33():155-61. PubMed ID: 782963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of peroral and intranasal immunization of school children with live allantoic influenza vaccine- and comparative study.
    Koval TA; Aleksandrova GI; Grunis AM; Ivannikov YuG ; Medvedeva TE; Sychev SV; Shaposhnikova RP; Smorodintsev AA
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):194-200. PubMed ID: 395255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

  • 16. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to combined live influenza virus vaccines administered intranasally.
    Peetermans J; Lamy F; Delem A
    Dev Biol Stand; 1975; 28():340-6. PubMed ID: 1126578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.
    Halasa N; Englund JA; Nachman S; Weinberg GA; Huber VC; Allison K; Dubovsky F; Yi T; McCullers JA; Flynn PM
    Vaccine; 2011 May; 29(24):4110-5. PubMed ID: 21496468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.